Pathyaപഥ്യം
← New record

IndiPGx-Pop p086

Lab reportcohort · india-sim

10/30/2026, 1:54:26 PM · PharmCAT 3.4.0 · Research record, not medical advice

6
Genes standardised
6
Calls quoted
9
Coverage gaps
0
Identifiers removed
23.6s
Upload to record
  1. Muse Sparkread 6 gene calls17.0s
  2. PharmCATstandardised 6 genes6.6s
  3. Rules9 coverage gaps

CallsMuse Spark each call quoted from the source, then standardised by PharmCAT

Demo Precision Oncology Labs, Chennai · SYNTHETIC · 9 Oct 2026 · open original photo

Uploaded lab report photo
GeneAs printedStandardisedPhenotype term
CYP2C19“CYP2C19. Genotype *17/*2, consistent with a intermediate metabolizer.”*17/*2Intermediate Metabolizer
CYP2D6“CYP2D6. Genotype *1/*1, consistent with a normal metabolizer (activity score 2).”*1/*1Normal Metabolizer · activity 2.0
DPYD“DPYD. No variant from the tested DPYD panel was detected. Predicted DPD phenotype: normal metabolizer (activity score 2).”Reference/ReferenceNormal Metabolizer · activity 2.0
NUDT15“NUDT15. Genotype *1/*1, consistent with a normal metabolizer.”*1/*1Normal Metabolizer
TPMT“TPMT. Genotype *1/*1, consistent with a normal metabolizer.”*1/*1Normal Metabolizer
UGT1A1“UGT1A1. Genotype *1/*1 (TA6/TA6), consistent with a normal metabolizer.”*1/*1Normal Metabolizer

Method as printed: Sample: peripheral blood (EDTA). Method: targeted genotyping by real-time PCR. Only the listed variants are assayed; variants outside this panel cannot be excluded.

Coveragedeterministic rules · which India-relevant variants this panel named

DPYDHapB3panel not documented

Most common Indian decreased-function DPYD variant (~3.3%, PMID 40810747)

DPYDc.85T>C (*9A)panel not documented

~25% in Indians; toxicity signal in South Indian cohorts (PMC11300675)

DPYD*2Apanel not documented

European tier-1 variant; rare in Indians (PMID 40810747)

DPYD*13panel not documented

Tier-1 no-function variant (PMID 39032821)

DPYDc.2846A>Tpanel not documented

Tier-1 variant; near-absent in Indians (PMID 40810747)

NUDT15*3panel not documented

Main NUDT15 risk allele, ~7-11% in Indians (PMID 29470173)

UGT1A1*28panel not documented

TA-repeat allele, common in South Asians

UGT1A1*6panel not documented

East Asian allele; reported at low frequency in India

TPMT*3Cpanel not documented

Most common TPMT variant in South Asians

CYP2C19*2named on the report

Common no-function allele in South Asians

CYP2C19*17named on the report

Increased-function allele

A variant the panel did not name is left out of cohort statistics for that variant, rather than counted as absent. Reader notes: Targeted genotyping panel: no variant list provided; variants outside this panel cannot be excluded. Synthetic document generated for software benchmarking. Not a real patient or laboratory.

Exportde-identified · the same record in three formats

Curator review

A curator checks each call against the source document before the record counts in a cohort, and Muse Spark web search finds published Indian frequency data for each variant. Both are written to the audit log. Reviewing is the one action that needs a curator code, because it is a claim that a person checked the page.

Sign in as a curator
Research tool, not medical advice. Pathya reads and standardises pharmacogenomic results; it makes no dose, drug or test recommendation. Audit log: data/cases/95a7d563e1b5/audit.log.